Our Website Uses Cookies 


We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.


For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

China Enacts Biosecurity Law

December 9, 2020, Covington Alert

On October 17, 2020, the Standing Committee of National People's Congress (“NPCSC”), China’s top legislative body, adopted a Biosecurity Law (“Law”), which will go into effect on April 15, 2021. The Law reflects a growing area of regulation of drugs and medical devices in China that is separate from the regulations to ensure safety, effectiveness, and quality of drug and device products. The Law addresses a number of different areas, from bioterrorism to the regulation of plant, animal, and human specimens, and may bring new risks for life sciences companies to consider with respect to their development plans in China. Implementing regulations, which could be issued over the next five months, should help clarify the Law’s impact.

This alert summarizes the key features of the Law.

Share this article: